Medicus Pharma Ltd (MDCX)

$2.38 -0.19 (-7.39%)
Market Cap 34.88M
Revenue (ttm) 0.00
Net Income (ttm) -11.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 374,452
Avg Vol 451,806
Day's Range N/A - N/A
Shares Out 13.57M
Stochastic %K 26%
Beta N/A
Analysts Strong Sell
Price Target $16.15

Company Profile

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets. It develops SkinJect for the treatment of basal cell carcinoma. The company was founded in 2015 and is headquartered in Toronto, Canada.

Industry: Drug Manufacturers - General
Sector: Healthcare
Address:
One First Canadian Place, Suite 3400 100 King Street West, Toronto, Canada
2TrustHim
2TrustHim Aug. 4 at 4:34 PM
$MDCX At Least$6.00 already Portfolio Building Machine
0 · Reply
2TrustHim
2TrustHim Aug. 4 at 3:33 PM
$MDCX Looks Like People are just trying to figure out how many varying interests our company is getting involved in!!! Spreading out in all areas. No wonder why the very high Price Target!!!
0 · Reply
DARKP00L
DARKP00L Aug. 4 at 11:52 AM
$MDCX 07:39 on Aug. 04 2025 Medicus and HelixNano Team Up to Develop Needle-Free, Thermostable mRNA Vaccines #tradeideas
0 · Reply
newsfile_corp
newsfile_corp Aug. 4 at 11:32 AM
https://nfne.ws/261071 $MDCX #Chemicals #Banking #Biotechnology #FinancialServices #InvestmentBanking #NASDAQ #Investing
0 · Reply
XkaliburTrading
XkaliburTrading Aug. 4 at 11:30 AM
$MDCX https://www.newsfilecorp.com/release/261071/Medicus-Pharma-Ltd.-Announces-a-Memorandum-of-Understanding-MOU-with-Helix-Nanotechnologies-Inc.-to-Develop-Thermostable-Infectious-Disease-Vaccines
0 · Reply
ArrcAngel
ArrcAngel Aug. 1 at 4:59 PM
$MDCX I don't worry about the 129k short interest. At 42% borrow rate, it's a losing trade before it begins.
0 · Reply
ArrcAngel
ArrcAngel Jul. 31 at 7:35 PM
$MDCX July tutes
0 · Reply
ArrcAngel
ArrcAngel Jul. 31 at 7:30 PM
$MDCX Hey remember that deep pocket investor I put up here a (minute) ago? He's now on the BOD. Ajay Raju
0 · Reply
ArrcAngel
ArrcAngel Jul. 31 at 7:15 PM
$MDCX Q2 has past, should be any day that we here something about the FDA C meeting or results from UAE.
0 · Reply
ArrcAngel
ArrcAngel Jul. 31 at 5:25 PM
$MDCX Back in on the lower band regression line. Shake n Bake.
0 · Reply
Latest News on MDCX
Medicus Pharma Ltd. Announces a Memorandum of Understanding (MOU) with Helix Nanotechnologies Inc. to Develop Thermostable Infectious Disease Vaccines

Aug 4, 2025, 7:30 AM EDT - 11 hours ago

Medicus Pharma Ltd. Announces a Memorandum of Understanding (MOU) with Helix Nanotechnologies Inc. to Develop Thermostable Infectious Disease Vaccines

Medicus Pharma Ltd. Announces Voting Results Following the Annual and Special Meeting of Shareholders

Jul 23, 2025, 7:30 AM EDT - 12 days ago

Medicus Pharma Ltd. Announces Voting Results Following the Annual and Special Meeting of Shareholders

Medicus Pharma Ltd. to Present at BTIG Virtual Biotech Conference 2025

Jul 21, 2025, 7:30 AM EDT - 14 days ago

Medicus Pharma Ltd. to Present at BTIG Virtual Biotech Conference 2025

Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)

Jul 8, 2025, 7:30 AM EDT - 27 days ago

Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)

Medicus Pharma: High-Risk But Higher Reward For Their Potential Breakthrough Skin Cancer Treatment

Jul 4, 2025, 9:49 AM EDT - 4 weeks ago

Medicus Pharma: High-Risk But Higher Reward For Their Potential Breakthrough Skin Cancer Treatment

Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK

Jun 30, 2025, 7:30 AM EDT - 5 weeks ago

Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK

Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer

Jun 23, 2025, 7:30 AM EDT - 6 weeks ago

Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer

Medicus Pharma Ltd. to Present at 2025 Bio International Convention

Jun 12, 2025, 7:30 AM EDT - 7 weeks ago

Medicus Pharma Ltd. to Present at 2025 Bio International Convention

Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses

Jun 9, 2025, 7:30 AM EDT - 2 months ago

Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses

Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

Jun 2, 2025, 1:40 PM EDT - 2 months ago

Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering

May 29, 2025, 8:30 PM EDT - 2 months ago

Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering

Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

May 22, 2025, 7:30 AM EDT - 2 months ago

Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio

May 12, 2025, 2:20 PM EDT - 3 months ago

Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio

Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd.

Apr 28, 2025, 7:30 AM EDT - 3 months ago

Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd.

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)

Apr 21, 2025, 7:30 AM EDT - 3 months ago

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)

Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering

Mar 10, 2025, 4:05 PM EDT - 5 months ago

Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering

Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering

Mar 6, 2025, 8:30 PM EST - 5 months ago

Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering

Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Mar 6, 2025, 7:30 AM EST - 5 months ago

Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Feb 27, 2025, 7:30 AM EST - 5 months ago

Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)

Feb 11, 2025, 7:41 AM EST - 6 months ago

Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

Dec 12, 2024, 7:30 AM EST - 8 months ago

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

Dec 2, 2024, 7:30 AM EST - 8 months ago

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Nov 18, 2024, 7:30 AM EST - 9 months ago

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States

Nov 15, 2024, 4:47 PM EST - 9 months ago

Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States

Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States

Nov 13, 2024, 6:45 PM EST - 9 months ago

Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States

2TrustHim
2TrustHim Aug. 4 at 4:34 PM
$MDCX At Least$6.00 already Portfolio Building Machine
0 · Reply
2TrustHim
2TrustHim Aug. 4 at 3:33 PM
$MDCX Looks Like People are just trying to figure out how many varying interests our company is getting involved in!!! Spreading out in all areas. No wonder why the very high Price Target!!!
0 · Reply
DARKP00L
DARKP00L Aug. 4 at 11:52 AM
$MDCX 07:39 on Aug. 04 2025 Medicus and HelixNano Team Up to Develop Needle-Free, Thermostable mRNA Vaccines #tradeideas
0 · Reply
newsfile_corp
newsfile_corp Aug. 4 at 11:32 AM
https://nfne.ws/261071 $MDCX #Chemicals #Banking #Biotechnology #FinancialServices #InvestmentBanking #NASDAQ #Investing
0 · Reply
XkaliburTrading
XkaliburTrading Aug. 4 at 11:30 AM
$MDCX https://www.newsfilecorp.com/release/261071/Medicus-Pharma-Ltd.-Announces-a-Memorandum-of-Understanding-MOU-with-Helix-Nanotechnologies-Inc.-to-Develop-Thermostable-Infectious-Disease-Vaccines
0 · Reply
ArrcAngel
ArrcAngel Aug. 1 at 4:59 PM
$MDCX I don't worry about the 129k short interest. At 42% borrow rate, it's a losing trade before it begins.
0 · Reply
ArrcAngel
ArrcAngel Jul. 31 at 7:35 PM
$MDCX July tutes
0 · Reply
ArrcAngel
ArrcAngel Jul. 31 at 7:30 PM
$MDCX Hey remember that deep pocket investor I put up here a (minute) ago? He's now on the BOD. Ajay Raju
0 · Reply
ArrcAngel
ArrcAngel Jul. 31 at 7:15 PM
$MDCX Q2 has past, should be any day that we here something about the FDA C meeting or results from UAE.
0 · Reply
ArrcAngel
ArrcAngel Jul. 31 at 5:25 PM
$MDCX Back in on the lower band regression line. Shake n Bake.
0 · Reply
2TrustHim
2TrustHim Jul. 30 at 4:23 PM
$MDCX Don’t miss out on the opportunity to get in this low!!!
0 · Reply
2TrustHim
2TrustHim Jul. 30 at 3:26 PM
$MDCX Read Between the Lines!!!
1 · Reply
2TrustHim
2TrustHim Jul. 30 at 3:25 PM
$MDCX Wow the Deloitte News is huge The Product is working so good they expect a Partner!!!
0 · Reply
Canadianinvestor01
Canadianinvestor01 Jul. 30 at 2:45 PM
$MDCX Medicus Pharma appoints Deloitte as adviser for potential D-MNA out-licensing Investing.com 3 hours ago Maybe D Boral Capital and Maxim Group were incompetent for such a task unable to pump the stock to their ridiculus target.
0 · Reply
bullrider19
bullrider19 Jul. 29 at 10:54 PM
$MDCX new price target $1.35 down from $27 ooooooops
2 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 29 at 8:05 PM
$MDCX Outstanding article that hits the mark on MDCX's current state. So if you want to refresh your MDCX insights or learn about MDCX from scratch, this is a must read. https://beyondspx.com/article/medicus-pharma-building-a-biotech-pipeline-through-innovation-and-acquisition-nasdaq-mdcx
0 · Reply
2TrustHim
2TrustHim Jul. 29 at 7:42 PM
$MDCX WOW Can't hold a gain that should be way higher in the first place!!!
0 · Reply
Fib7867
Fib7867 Jul. 29 at 2:34 AM
#myMDCXanalysis $MDCX #MarsTUE #TuesdayZ
0 · Reply
Rocco59
Rocco59 Jul. 28 at 7:31 PM
$MDCX I also have been looking all day can’t find anything
0 · Reply
GanymedeSpecial
GanymedeSpecial Jul. 28 at 7:19 PM
$MDCX What the hell happened here? I can't find any news.
0 · Reply
2TrustHim
2TrustHim Jul. 28 at 5:57 PM
$MDCX Looks Like A lot of Shorts Need to Buy Up Soon!!!
0 · Reply
bullrider19
bullrider19 Jul. 28 at 5:53 PM
$MDCX now buying big money give it 3 months $$$$$$ 15k shares
0 · Reply